Graham Sandford, Department of Chemistry
Research into manufacture of life-saving drug wins industry-sponsored award. April 2018) Durham University chemists have won a national award for research that could increase the availability of an effective treatment for a strain of meningitis in less developed countries. Professor Graham Sandford will receive the 2018 AstraZeneca, GlaxoSmithKline (GSK), Pfizer and Syngenta Prize for Process Chemistry Research on behalf of the Durham Fluorine Group. This is the 13th time the annual prize has been awarded to a UK based academic who has developed chemistry that has the potential to be of relevance to large scale manufacturing. The Durham group's work could see drugs for the treatment of Cryptococcal Meningitis (CM) become more readily available. Reducing cost of vital medicine CM is the leading cause of meningitis in sub-Saharan Africa and also accounts for 20 per cent of HIV/AIDs related deaths worldwide. In developed nations around nine per cent of those diagnosed with CM die, but this figure rises to 70 per cent in sub-Saharan Africa where the availability of suitable drug treatment is limited, due in part to cost.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
